Concepedia

Gary Simmons

GS

Statistics

Publications

14

Citations

716

H-Index

12

Active since

2012

Affiliations

Virginia Commonwealth University(Current)

The University of Texas MD Anderson Cancer Center

Levine Cancer Institute

Stanford University

Huntsman Cancer Institute

Gary Simmons is an author at Virginia Commonwealth University specializing in medicine, oncology, and multiple myeloma.

Publications per year

2012–2024

14

Publications

14

Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: Real-World Experience From the Myeloma CAR T Consortium

Doris K. Hansen, Surbhi Sidana, Lauren C. Peres et al. · Journal of Clinical Oncology · 2023 · 279 citations · Full text

Medicine, Immunology, Oncology +15

Real-world experience of patients with multiple myeloma receiving ide-cel after a prior BCMA-targeted therapy

Christopher J. Ferreri, Michelle A.T. Hildebrandt, Hamza Hashmi et al. · Blood Cancer Journal · 2023 · 111 citations · Full text

Medicine, Hematology, Oncology +17

CDK Inhibitors Upregulate BH3-Only Proteins to Sensitize Human Myeloma Cells to BH3 Mimetic Therapies

Shuang Chen, Yun Dai, Xin-Yan Pei et al. · Cancer Research · 2012 · 57 citations · Full text

Medicine, Oncology, Pharmacology +17

Idecabtagene vicleucel chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma with renal impairment

Surbhi Sidana, Lauren C. Peres, Hamza Hashmi et al. · Haematologica · 2023 · 41 citations · Full text

Medicine, Immunology, Nephrology +15

Real-world outcomes of axicabtagene ciloleucel in adult patients with primary mediastinal B-cell lymphoma

Jennifer L. Crombie, Loretta J. Nastoupil, Robert Redd et al. · Blood Advances · 2021 · 36 citations · Full text

Medicine, Oncology, Pharmacology +6

1–5 of 14